FDA Investigator Monica E Murie

Monica E Murie has conducted inspections on 17 sites in 3 countries as of 29 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
17
Last Inspection Date:
29 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
100001092
Countries of Inspections:
Netherlands, Sweden, United States of America
FDA Investigators that have inspected at least one site in common with Monica E Murie:
Adree N Anderson, Akbar J Zaidi, Alan M Barker, Ana Paulap Sandee, Anthony J Ladner, Anthony R Bucks, April L Young, Arsen Karapetyan, Bei Y He, Bo Chi, PhD, Brent M Dehaan, Brian A Roelofs, Bryan S Roddy, Burnell M Henry, Carl A Huffman, III, Conner N Mann, Courtney E Hillier, Courtney R Ingalsbe, Courtney R Tiegs, Cynthia M Goudeau, Dacia E Quick, Danial S Hutchison, Darrah, David J Eide, David M Beltran, Derrionna M Epps, Dewayne E Whitlock, Diana K Krepel, Dilip Devineni, PhD, Dustin K Hampton, Dwight D Ferguson, Edward E Lockwood (EEL), Elizabeth L Holmes, Eric C Nielsen, Eric M Mueller, PharmD, Eric M Padgett, Erika V Butler, Ewa Marszal, PhD, Fannie M Harrell, Frederick F Razzaghi, Gloria J Champagne, Gregory A Berg, Gwyn G Dickinson, Hamet M Toure, PharmD MPH, Helen B Ricalde, Ian L Mcwilliams, Ingrid Y Johnson, Jacob G Lutz, James I Giefer, James P Mcreavey, Jason H Wieners, Jennifer Cahill, Jill J Tillman, Jose Acruz Gonzalez, Joseph A Piechocki, Joseph R Lambert, Joslyn K Brunelle, PhD, Kalavati Suvarna, PhD, Karen C Daugherty, Karen M Montgomery (KMM), Kathleen B Swat, Kellia N Hicks, Krista K Petersen, Lauren N Howard, Laurie Graham, LCDR Ismael Olvera, IV, Linda F Murphy, Linhart, Lisa L Flores, Loan Chin, Logan T Williams, Marie A Fadden, Mark G Peterson, Massod Rahimi, PhD, Matthew M Schuckmann, Matthew Schuckman, Meisha R Sampson, Michael C Zubelewicz, Michael Shanks, MS, Michele L Glendenning, Michele L Obert, Michele Perry Williams, Minerva Rogers, Monica M Mcclure, Mra Davism, Norman K Starks, Omotunde O Osunsanmi, Philip J Boston, Rebecca L Caulfield, Richard Ledwidge (nmi), PhD, Robert J Ham, Ross J Grigsby, Russell J Glapion, Shafiq S Ahadi, Shanna R Haden, Sharon K Thoma, PharmD, Sherry G Bous, Shirley J Berryman, Sidney B Priesmeyer, Soyinka S Eneng, Sri Ramakrishnaiah Yellela, PhD, Srinivas R Chennamaneni, PhD, Steven D Kehoe, Steven P Allen, Susan D Yuscius, Tara L Breckenridge, Tara L Greene, Tara L King, Thomas J Arista, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Tiffani D Wilson, Torrey M Ward, Veronica Fuentes, MS, Victoria P Quadrini, Vikas Moolchandani, Warren J Lopicka, Wayne D Mcgrath, William C Corley, Xiaohan Cai, PhD, Xiaoshi N Wang, Yiyue Zhang (nmi), PhD, Yongmin Liu, Zhang Zhao, PhD

Monica E Murie's Documents

Publish Date Document Type Title
August, 2023 FDA 483 Apex International Mfg., LLC - Form 483, 2023-08-11
June, 2023 FDA 483 Consumer Product Partners, LLC - Form 483, 2023-06-14
March, 2024 FDA 483 ILMO Products Company - Form 483, 2024-03-28
September, 2023 FDA 483 SpecGx LLC - Form 483, 2023-09-18
December, 2023 FDA 483 Patheon Biologics LLC - Form 483, 2023-12-08
February, 2024 FDA 483 Sentio BioSciences LLC - Form 483, 2024-02-06
November, 2023 FDA 483 STERIS Corporation - Form 483, 2023-11-06
March, 2023 FDA 483 Rechon Life Science AB - Form 483, 2023-03-17
September, 2022 FDA 483 Marcus Research Laboratory, Inc. - Form 483, 2022-09-02
November, 2022 FDA 483 S&B Pharma LLC DBA Alkem Laboratories - Form 483, 2022-11-08
September, 2022 FDA 483 Missouri Analytical Laboratories, Inc. - Form 483, 2022-09-02
May, 2024 FDA 483 ALI Pharmaceutical Manufacturing, LLC - Form 483, 2024-05-03
January, 2023 FDA 483 Huvepharma, Inc. - Form 483, 2023-01-30
August, 2022 FDA 483 Consolidated Chemical, Inc. DBA CARE-TECH Laboratories, Inc. - Form 483, 2022-08-02
July, 2023 FDA 483 Eco Lips, Inc. - Form 483, 2023-07-14
August, 2024 FDA 483 Baxter Healthcare Corporation - Form 483, 2024-08-01
December, 2024 FDA 483 LW Chemicals, INC - Form 483, 2024-12-03
September, 2024 FDA 483 Zhejiang Bamboo Pharmaceuticals Co.,Ltd - Form 483, 2024-09-27
September, 2024 FDA 483 Shanghai Chuangshi Medical Technology (Group) Co., Ltd. - Form 483, 2024-09-13

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more